CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Mar 17, 2025. (Total: 6589 publications)

All Cancer Diabetes Economic Environmental Equity FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Records 1-19 (of 19 Records)

Query Trace: Guillain-barre Syndrome[original query]
Post-licensure safety surveillance of 20-valent pneumococcal conjugate vaccine (PCV20) among US adults in the Vaccine Adverse Event Reporting System (VAERS) Oliveira M , Marquez P , Ennulat C , Blanc P , Welsh K , Nair N , Taminato M , Moro PL . Drug Saf 2024
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals Faksova K , Walsh D , Jiang Y , Griffin J , Phillips A , Gentile A , Kwong JC , Macartney K , Naus M , Grange Z , Escolano S , Sepulveda G , Shetty A , Pillsbury A , Sullivan C , Naveed Z , Janjua NZ , Giglio N , Perälä J , Nasreen S , Gidding H , Hovi P , Vo T , Cui F , Deng L , Cullen L , Artama M , Weintraub E , Lu H , Clothier HJ , Batty K , Paynter J , Petousis-Harris H , Buttery J , Black S , Hviid A . Vaccine 2024
Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries. Goud R , Lufkin B , Duffy J , Whitaker B , Wong HL , Liao J , Lo AC , Parulekar S , Agger P , Anderson SA , Wernecke M , MaCurdy TE , Weintraub E , Kelman JA , Forshee RA . JAMA Intern Med 2021 181 (12) 1623-1630
Surveillance for Adverse Events After COVID-19 mRNA Vaccination. Klein NP , Lewis N , Goddard K , Fireman B , Zerbo O , Hanson KE , Donahue JG , Kharbanda EO , Naleway A , Nelson JC , Xu S , Yih WK , Glanz JM , Williams JTB , Hambidge SJ , Lewin BJ , Shimabukuro TT , DeStefano F , Weintraub ES . JAMA 2021 326 (14) 1390-1399
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. LaRovere KL , Riggs BJ , Poussaint TY , Young CC , Newhams MM , Maamari M , Walker TC , Singh AR , Dapul H , Hobbs CV , McLaughlin GE , Son MBF , Maddux AB , Clouser KN , Rowan CM , McGuire JK , Fitzgerald JC , Gertz SJ , Shein SL , Munoz AC , Thomas NJ , Irby K , Levy ER , Staat MA , Tenforde MW , Feldstein LR , Halasa NB , Giuliano JS Jr , Hall MW , Kong M , Carroll CL , Schuster JE , Doymaz S , Loftis LL , Tarquinio KM , Babbitt CJ , Nofziger RA , Kleinman LC , Keenaghan MA , Cvijanovich NZ , Spinella PC , Hume JR , Wellnitz K , Mack EH , Michelson KN , Flori HR , Patel MM , Randolph AG . JAMA Neurol 2021 78 (5) 536-547
The Brighton Collaboration case definition: comparison in a retrospective and prospective cohort of children with Guillain-Barré syndrome. Korinthenberg R , Sejvar JJ . J Peripher Nerv Syst 2020 25 (4) 344-349
Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016. Myers TR , McNeil MM , Ng CS , Li R , Marquez PL , Moro PL , Omer SB , Cano MV . Vaccine 2020 38 (40) 6291-6298
Guillain-Barré syndrome in times of pandemics. Leonhard SE , Cornblath DR , Endtz HP , Sejvar JJ , Jacobs BC . J Neurol Neurosurg Psychiatry 2020 91 (10) 1027-1029
A systematic review and evaluation of Zika virus forecasting and prediction research during a public health emergency of international concern. Kobres PY , Chretien JP , Johansson MA , Morgan JJ , Whung PY , Mukundan H , Del Valle SY , Forshey BM , Quandelacy TM , Biggerstaff M , Viboud C , Pollett S . PLoS Negl Trop Dis 2019 13 (10) e0007451
Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ⩾19years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012-December 31, 2015. Haber P , Arana J , Pilishvili T , Lewis P , Moro PL , Cano M . Vaccine 2016 34 (50) 6330-6334
Development and Characterization of Recombinant Virus Generated from a New World Zika Virus Infectious Clone. Weger-Lucarelli J , Duggal NK , Bullard-Feibelman K , Veselinovic M , Romo H , Nguyen C , Ruckert C , Brault AC , Bowen RA , Stenglein M , Geiss BJ , Ebel GD . J Virol 2016 91 (1)
Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015. Moro PL , Woo EJ , Paul W , Lewis P , Petersen BW , Cano M . PLoS Negl Trop Dis 2016 10 (7) e0004846
Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015. Haber P , Moro PL , Lewis P , Woo EJ , Jankosky C , Cano M . Vaccine 2016 34 (22) 2507-12
Public Health and Rare Diseases: Oxymoron No More. Valdez R , Ouyang L , Bolen J . Prev Chronic Dis 2016 13 E05
Surveillance of adverse events after the first trivalent inactivated influenza vaccine produced in mammalian cell culture (Flucelvax(®)) reported to the Vaccine Adverse Event Reporting System (VAERS), United States, 2013-2015. Moro PL , Winiecki S , Lewis P , Shimabukuro TT , Cano M . Vaccine 2015 33 (48) 6684-8
Post-Licensure Surveillance of Trivalent Live-Attenuated Influenza Vaccine in Children Aged 2-18 Years, Vaccine Adverse Event Reporting System, United States, July 2005-June 2012. Haber P , Moro PL , Cano M , Vellozzi C , Lewis P , Woo EJ , Broder K . J Pediatric Infect Dis Soc 2015 4 (3) 205-13
Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014. Haber P , Moro PL , Cano M , Lewis P , Stewart B , Shimabukuro TT . Vaccine 2015 33 (16) 1987-92
Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013. Haber P , Moro P , McNeil MM , Lewis P , Woo EJ , Hughes H , Shimabukuro TT . Vaccine 2014 32 (48) 6499-504
Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010. Moro PL , Arana J , Cano M , Menschik D , Yue X , Lewis P , Haber P , Martin D , Broder K . Clin Infect Dis 2012 54 (11) 1608-14